The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.

GE HealthCare Technologies Inc. (NASDAQ:GEHC) is one of the best up and coming stocks with highest upside potential. On April 29, GE HealthCare reported total revenues of $5.1 billion for Q1 2026, marking a 7.4% increase, with organic revenue growth contributing 2.9%. This growth was fueled by strong commercial performance in the Pharmaceutical Diagnostics/PDx, Imaging, and Advanced Visualization Solutions segments.

While total organic orders rose by 1.1%, the company maintained a robust backlog of $21.8 billion and a book-to-bill ratio of 1.07 times. Additionally, the quarter was highlighted by the $2.3 billion acquisition of Intelerad, a move intended to strengthen the company’s cloud-based enterprise imaging capabilities. Despite the positive topline results, profitability was pressured by several headwinds, including a temporary PDx supplier issue that has since been resolved. GE HealthCare Technologies Inc. (NASDAQ:GEHC) reported a net income margin of 7.6% and an adjusted EBIT margin of 13.5%, while diluted EPS stood at $0.85 and adjusted EPS at $0.99.

Looking ahead, GE HealthCare has reaffirmed its organic revenue growth guidance of 3.0% to 4.0% based on healthy global demand. However, the company lowered its full-year outlook for profit and free cash flow due to more pronounced inflationary pressures on memory chips, oil, and freight costs. The updated guidance now projects an adjusted EPS range of $4.80 to $5.00 and free cash flow of approximately $1.6 billion.

Source: Unsplash

GE HealthCare Technologies Inc. (NASDAQ:GEHC) is a healthcare company with a focus on various products, services, and digital solutions made for diagnoses and treatments. The company operates through Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics segments.

While we acknowledge the potential of GEHC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey on Google News.